Market revenue in 2023 | USD 159.7 million |
Market revenue in 2030 | USD 205.4 million |
Growth rate | 3.7% (CAGR from 2023 to 2030) |
Largest segment | Carbohydrates |
Fastest growing segment | Carbohydrates |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Carbohydrates, Proteins, Polymers, Minerals, Glycoside & Waxes, Esters, Ethers & Carboxylic Acids, Other Chemical Natures |
Key market players worldwide | Basf SE, Lonza Group Ltd, Evonik Industries AG, Roquette America, JRS Pharma, Micro Powders, Fumeipharm, Cristalco |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plant-based excipients market will help companies and investors design strategic landscapes.
Carbohydrates was the largest segment with a revenue share of 21.16% in 2023. Horizon Databook has segmented the Germany plant-based excipients market based on carbohydrates, proteins, polymers, minerals, glycoside & waxes, esters, ethers & carboxylic acids, other chemical natures covering the revenue growth of each sub-segment from 2018 to 2030.
Over 660 pharmaceutical players and multinational companies’ subsidiaries are based in Germany. Highly skilled workers, strong healthcare infrastructure, and a strong & evolving consumer health market are some of the factors playing an important role in pharmaceutical development in the country, and this is also creating competition among players in the Germany market.
Market players in the country are launching new vegan-based drugs. For instance, in February 2022, German-based auxin launched Paraveganio, which is a vegan paracetamol using plant-based excipients. Similarly, in March 2022, Evonik expanded the production of its Phyto Chol plant in Germany for the production of mRNA vaccines.
Such initiatives indicate that there is a growing demand for plant based products in the country. This is expected to support the growth of the Germany plant-based excipients market. German-based companies are using different types of plant-based excipients owing to the growing demand for vegan products in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany plant-based excipients market , including forecasts for subscribers. This country databook contains high-level insights into Germany plant-based excipients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account